Related Experiment Video
Updated: Oct 7, 2026
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
[Whole blood flow cytometry for detection of activated platelets. I. Platelet identification, blood collection and
1Department of Laboratory Medicine, School of Medicine, Tokai University, Isehara 259-1193.
Abstract:
In order to assess platelet activation by flow cytometry and activation-dependent monoclonal antibodies, a minute volume(2.5 microliters) of citrated whole blood was mixed for 15 minutes with a cocktail of monoclonal antibodies(MoAb), including PAC1, (a MoAb specific for fibrinogen receptors), and a MoAb against CD62P, (an alpha-granule membrane protein which associates with platelet surface membranes when platelets are activated). After fixation with 1% formaldehyde, the percentage of platelets positive for PAC1 and/or MoAb-CD62P was measured by flow cytometry. Even in resting platelets without stimulation, about 15% of platelets were found to be PAC1-positive and 0.6% of platelets were CD62P-positive. If there was a one-minute delay after needle puncture and before blood collection, the number of PAC1-positive platelets was increased compared to that of blood obtained immediately after puncture. If blood was allowed to stand at room temperature, there was a gradual increase in the number of PAC1-positive platelets, and after 60 minutes, this increase became statistically significant. The addition of Iloprost, (a prostacyclin analogue), immediately after venipuncture did not completely prevent the increase in PAC1-positive platelets after 60 minutes. If the inhibitor was added after first incubating for 60 minutes, however, the percentage of PAC1-positive platelets was reduced to preincubation value. Although flow cytometry is a simple and powerful tool to assess platelet activation, there remain several methodological problems to be resolved before this method may be employed in routine clinical use.
Insights
Flow cytometry can assess platelet activation, but pre-analytical variables like delayed blood collection increase PAC1-positive platelets. Iloprost can reduce activation if added promptly, highlighting methodological challenges for clinical use.
Area of Science:
- Hematology
- Immunology
- Biotechnology
Context:
- Platelet activation is crucial in hemostasis and thrombosis.
- Flow cytometry offers a sensitive method to detect platelet activation markers.
- Standardizing pre-analytical conditions is vital for reliable flow cytometry results.
Purpose:
- To evaluate platelet activation using flow cytometry and activation-dependent monoclonal antibodies (MoAb).
- To investigate the impact of pre-analytical variables, such as delayed blood collection and incubation time, on platelet activation markers.
- To assess the efficacy of Iloprost in mitigating ex vivo platelet activation.
Summary:
- A study assessed platelet activation using monoclonal antibodies (MoAb) PAC1 and CD62P via flow cytometry.
- Delayed blood collection and room temperature incubation significantly increased PAC1-positive platelets, indicating ex vivo activation.
- Prompt addition of Iloprost reduced activation, but delayed addition was less effective, underscoring the importance of timing.
Impact:
- Highlights methodological challenges in using flow cytometry for routine clinical assessment of platelet activation.
- Emphasizes the need for strict pre-analytical protocols to ensure accurate platelet function testing.
- Provides insights into the kinetics of ex vivo platelet activation and the potential role of inhibitors.
